Trial Profile
Open, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer After Failure or Intolerability to Second-line Standard Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Depoxythilone (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Beijing Biostar Technologies
- 15 Jun 2023 According to a Biostar media release, the data from this study were presented at the 2022 ELCC (European Lung Cancer Congress) as poster presentation.
- 15 Jun 2023 Results presented in the Biostar Pharma Media Release.
- 08 Jan 2023 Status changed from recruiting to completed.